Stay Connected With Us
Nov 09, 2020 AM EST
The phase II trial of a monoclonal antibody called BIIB059, which hinders the production of interferon type 1, exhibited effectiveness in patients who had active systemic lupus erythematosus or SLE.
Jun 18, 2020 AM EDT
In a study, researchers found that strong antibodies extracted from patients, when injected to hamsters, will neutralize the infection.
Jun 03, 2020 AM EDT
Last Monday, the American pharmaceutical company Eli Lilly and Company had carried out human trials for the world's first potential antibody treatment against COVID-19, starring an antibody called LY-CoV555.
